Table 2.
Variables | Number | Overall Survival | Log-Rank | |
---|---|---|---|---|
Median Survival Days | Survival (%) | |||
Gender | ||||
Female | 70 | 845 | 91.4 | 0.068 |
Male | 282 | 741 | 83.3 | |
Recurrence | ||||
Negative | 291 | 804 | 90.3 | <0.001 |
Positive | 61 | 599 | 59.0 | |
Differentiation | ||||
Well/Moderate | 168 | 804 | 86.9 | 0.215 |
Poor | 184 | 736 | 83.1 | |
Clinical stage | ||||
Stage I, II | 276 | 818 | 92.0 | <0.001 |
Stage III, IV | 76 | 531 | 58.7 | |
Hepatitis B | ||||
Negative | 167 | 812 | 82.1 | 0.607 |
Positive | 185 | 740 | 83.3 | |
Hepatitis C | ||||
Negative | 235 | 732 | 82.1 | 0.463 |
Positive | 117 | 848 | 84.5 | |
LGR-5 | ||||
Low | 163 | 755 | 89.6 | 0.020 |
High | 189 | 741 | 80.9 |